| protein phosphatase 2, catalytic subunit, alpha isoform | |||||||
|---|---|---|---|---|---|---|---|
The catalytic (C) subunit of protein phosphatase 2A. The protein is shown in rainbow color with theN-terminus in blue and theC-terminus in red. Themethylatedcarboxyl group of the C-terminalleucine residue is shown in white. The purple spheres are two catalytically requiredmanganese ions and the dark gray compound at center is a peptidomimetic toxin,microcystin, occupying theactive site. FromPDB:2IAE.[1] | |||||||
| Identifiers | |||||||
| Symbol | PPP2CA | ||||||
| NCBI gene | 5515 | ||||||
| HGNC | 9299 | ||||||
| OMIM | 176915 | ||||||
| RefSeq | NM_002715 | ||||||
| UniProt | P67775 | ||||||
| Other data | |||||||
| EC number | 3.1.3.16 | ||||||
| Locus | Chr. 5q23-q31 | ||||||
| |||||||
| protein phosphatase 2, catalytic subunit, beta isoform | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | PPP2CB | ||||||
| NCBI gene | 5516 | ||||||
| HGNC | 9300 | ||||||
| OMIM | 176916 | ||||||
| RefSeq | NM_001009552 | ||||||
| UniProt | P62714 | ||||||
| Other data | |||||||
| EC number | 3.1.3.16 | ||||||
| Locus | Chr. 8p12 | ||||||
| |||||||
Protein phosphatase 2(PP2), also known asPP2A, is anenzyme that in humans is encoded by thePPP2CAgene.[2][3] The PP2Aheterotrimericprotein phosphatase is ubiquitously expressed, accounting for a large fraction of phosphatase activity ineukaryotic cells.[4] Itsserine/threonine phosphatase activity has a broad substrate specificity and diverse cellular functions. Among the targets of PP2A are proteins of oncogenic signaling cascades, such asRaf,MEK, andAKT, where PP2A may act as a tumor suppressor.
PP2A consists of a dimeric core enzyme composed of the structural A and catalytic C subunits, and a regulatory B subunit. When the PP2A catalytic C subunit associates with the A and B subunits several species of holoenzymes are produced with distinct functions and characteristics. The A subunit, a founding member of theHEAT repeat protein family (huntingtin,EF3, PP2A,TOR1), is the scaffold required for the formation of the heterotrimeric complex. When the A subunit binds it alters the enzymatic activity of the catalytic subunit, even if the B subunit is absent. While C and A subunit sequences show remarkable sequence conservation throughout eukaryotes, regulatory B subunits are more heterogeneous and are believed to play key roles in controlling the localization and specific activity of different holoenzymes. Multicellulareukaryotes express four classes of variable regulatory subunits: B (PR55), B′ (B56 or PR61), B″ (PR72), and B‴ (PR93/PR110), with at least 16 members in these subfamilies. In addition, accessory proteins and post-translational modifications (such as methylation) control PP2A subunit associations and activities.
The two catalytic metal ions located in PP2A'sactive site aremanganese.[1]
| Function | Protein | Description | Note |
|---|---|---|---|
| Structural subunit A | PPP2R1A | PP2A 65 kDa regulatory subunit A alpha isoform | subunit A, PR65-alpha isoform |
| PPP2R1B | PP2A 65 kDa regulatory subunit A beta isoform | subunit A, PR65-beta isoform | |
| Regulatory subunit B | PPP2R2A | PP2A 55 kDa regulatory subunit B alpha isoform | subunit A, B-alpha isoform |
| PPP2R2B | PP2A 55 kDa regulatory subunit B beta isoform | subunit B, B-beta isoform | |
| PPP2R2C | PP2A 55 kDa regulatory subunit B gamma isoform | subunit B, B-gamma isoform | |
| PPP2R2D | PP2A 55 kDa regulatory subunit B delta isoform | subunit B, B-delta isoform | |
| PPP2R3A | PP2A 72/130 kDa regulatory subunit B | subunit B, B''-PR72/PR130 | |
| PPP2R3B | PP2A 48 kDa regulatory subunit B | subunit B, PR48 isoform | |
| PPP2R3C | PP2A regulatory subunit B'' subunit gamma | subunit G5PR | |
| PPP2R4 | PP2A regulatory subunit B' | subunit B', PR53 isoform | |
| PPP2R5A | PP2A 56 kDa regulatory subunit alpha isoform | subunit B, B' alpha isoform | |
| PPP2R5B | PP2A 56 kDa regulatory subunit beta isoform | subunit B, B' beta isoform | |
| PPP2R5C | PP2A 56 kDa regulatory subunit gamma isoform | subunit B, B' gamma isoform | |
| PPP2R5D | PP2A 56 kDa regulatory subunit delta isoform | subunit B, B' delta isoform | |
| PPP2R5E | PP2A 56 kDa regulatory subunit epsilon isoform | subunit B, B' epsilon isoform | |
| Catalytic subunit C | PPP2CA | catalytic subunit alpha isoform | |
| PPP2CB | catalytic subunit beta isoform |

PP2 has been identified as a potentialbiological target to discover drugs to treatParkinson's disease andAlzheimer's disease, however as of 2014 it was unclear which isoforms would be most beneficial to target, and also whether activation or inhibition would be most therapeutic.[6][7]
PP2 has also been identified as atumor suppressor forblood cancers, and as of 2015 programs were underway to identify compounds that could either directly activate it, or that could inhibit other proteins that suppress its activity.[8]